DISEASE INDICATIONS: HIV/AIDS

MANUFACTURER: ViiV Healthcare

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Cabenuva is a long-acting injectable medication used to treat HIV-1 infection in adult patients who have already been treated with both cabotegravir and rilpivirine and have achieved viral suppression. The medication contains two active ingredients, cabotegravir and rilpivirine, which work by inhibiting the activity of the reverse transcriptase enzyme and preventing the replication of HIV-1.